[
  {
    "ts": null,
    "headline": "CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo",
    "summary": "BMY obtains CHMP recommendation for Opdivo for perioperative regimen of neoadjuvant Opdivo and chemotherapy followed by surgery and adjuvant Opdivo for resectable non-small cell lung cancer.",
    "url": "https://finnhub.io/api/news?id=8186c85f3a1d86c01247505e2eeaf9c036bf19cf21103f0f1adb728ea577959b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743534000,
      "headline": "CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo",
      "id": 133658332,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY obtains CHMP recommendation for Opdivo for perioperative regimen of neoadjuvant Opdivo and chemotherapy followed by surgery and adjuvant Opdivo for resectable non-small cell lung cancer.",
      "url": "https://finnhub.io/api/news?id=8186c85f3a1d86c01247505e2eeaf9c036bf19cf21103f0f1adb728ea577959b"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day",
    "summary": "Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=ca120a7bac6689880cd9a51d87f11fb029fb500bf6996600c42c369f2b54c6ad",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743525420,
      "headline": "Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day",
      "id": 133662020,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=ca120a7bac6689880cd9a51d87f11fb029fb500bf6996600c42c369f2b54c6ad"
    }
  },
  {
    "ts": null,
    "headline": "Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?",
    "summary": "Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "url": "https://finnhub.io/api/news?id=15a158078add11bbf5ddaf13ff44a2dc86ac478c7e7646f5d0aaf4d328e0b9e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743523813,
      "headline": "Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?",
      "id": 133655253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
      "url": "https://finnhub.io/api/news?id=15a158078add11bbf5ddaf13ff44a2dc86ac478c7e7646f5d0aaf4d328e0b9e2"
    }
  },
  {
    "ts": null,
    "headline": "The FDA Is ‘Finished’ as Firings Sweep Health Agencies. Drug Stocks Are Falling.",
    "summary": "The FDA Is ‘Finished’ as Firings Sweep Health Agencies. Drug Stocks Are Falling.",
    "url": "https://finnhub.io/api/news?id=a97bb8bb4dd81521a6a0c69985f3f112753146db38962c05a885622fbfb743fd",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743516120,
      "headline": "The FDA Is ‘Finished’ as Firings Sweep Health Agencies. Drug Stocks Are Falling.",
      "id": 134147661,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "The FDA Is ‘Finished’ as Firings Sweep Health Agencies. Drug Stocks Are Falling.",
      "url": "https://finnhub.io/api/news?id=a97bb8bb4dd81521a6a0c69985f3f112753146db38962c05a885622fbfb743fd"
    }
  },
  {
    "ts": null,
    "headline": "Is Bristol-Myers Squibb (BMY) One of the Best Healthcare Stocks to Buy According to Billionaires?",
    "summary": "We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and […]",
    "url": "https://finnhub.io/api/news?id=80802300e6dfe21eece51f7a810ea3d45e98533b10f02d979ec79618d6f36f4d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743515549,
      "headline": "Is Bristol-Myers Squibb (BMY) One of the Best Healthcare Stocks to Buy According to Billionaires?",
      "id": 133645480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and […]",
      "url": "https://finnhub.io/api/news?id=80802300e6dfe21eece51f7a810ea3d45e98533b10f02d979ec79618d6f36f4d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=168ec70c45c96fc4aec72585b8e0a30df26b7e78fb29d02005ec75f46563937e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743512414,
      "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 133645481,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=168ec70c45c96fc4aec72585b8e0a30df26b7e78fb29d02005ec75f46563937e"
    }
  },
  {
    "ts": null,
    "headline": "Beat the S&P 500 With This Cash-Gushing Dividend Stock",
    "summary": "Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY).  At the time of writing, shares of the healthcare giant have climbed 4% year to date -- a notable outlier amid the broader stock market sell-off, with the S&P 500 index currently down nearly 10% from its peak.  Here's why this cash-generating biopharmaceutical leader is poised to continue outperforming the S&P 500.",
    "url": "https://finnhub.io/api/news?id=743f51606eb9b2bdbc0f07cbac339ea43a0410263553f9099493c19cc73ebfe8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743508800,
      "headline": "Beat the S&P 500 With This Cash-Gushing Dividend Stock",
      "id": 133645483,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY).  At the time of writing, shares of the healthcare giant have climbed 4% year to date -- a notable outlier amid the broader stock market sell-off, with the S&P 500 index currently down nearly 10% from its peak.  Here's why this cash-generating biopharmaceutical leader is poised to continue outperforming the S&P 500.",
      "url": "https://finnhub.io/api/news?id=743f51606eb9b2bdbc0f07cbac339ea43a0410263553f9099493c19cc73ebfe8"
    }
  },
  {
    "ts": null,
    "headline": "Impax Ellevate Global Women's Leadership Fund Q4 2024 Commentary",
    "summary": "In the fourth quarter, the Impax Ellevate Global Womenâs Leadership Fund outperformed the MSCI World Index (World Index). Read more here.",
    "url": "https://finnhub.io/api/news?id=102526a6609f2056dabffeeeabfb355e49408ad36589a7ce14636be23a3c19a5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743502260,
      "headline": "Impax Ellevate Global Women's Leadership Fund Q4 2024 Commentary",
      "id": 133639556,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/912015536/image_912015536.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "In the fourth quarter, the Impax Ellevate Global Womenâs Leadership Fund outperformed the MSCI World Index (World Index). Read more here.",
      "url": "https://finnhub.io/api/news?id=102526a6609f2056dabffeeeabfb355e49408ad36589a7ce14636be23a3c19a5"
    }
  }
]